Skip to main content
Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
53.20
+0.42 (0.80%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Doximity Revenue

Doximity had revenue of $168.60M in the quarter ending December 31, 2024, with 24.63% growth. This brings the company's revenue in the last twelve months to $550.17M, up 17.47% year-over-year. In the fiscal year ending March 31, 2024, Doximity had annual revenue of $475.42M with 13.45% growth.

Revenue (ttm)
$550.17M
Revenue Growth
+17.47%
P/S Ratio
18.03
Revenue / Employee
$665,258
Employees
827
Market Cap
9.98B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024475.42M56.37M13.45%
Mar 31, 2023419.05M75.50M21.98%
Mar 31, 2022343.55M136.65M66.05%
Mar 31, 2021206.90M90.51M77.76%
Mar 31, 2020116.39M30.69M35.82%
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

DOCS News

More News